Endocalyx Pro Studies
Endocalyx Pro, which healthcare practitioners recommend to patients for optimum microvascular health, continues to be studied by researchers for its impacts on multiple conditions and diseases.
Endocalyx Pro has completed, and has ongoing studies, that been running since 2015. These studies are in cell cultures, animals, and in humans. The studies in humans include double-blind placebo designs. These studies are on the following health conditions and diseases:
- COVID-19
- Aging
- Diabetes
- Kidney Disease
- Psoriasis
- Heart Diseases
- Sepsis
Functional studies on Endocalyx Pro™ are ongoing and planning to start in the following health conditions and diseases, two of which are COVID-19 studies that include Endocalyx Pro™. Go to Microvascular.com and read the abstracts for these studies:
- COVID-19 Study Abstract: Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients on ICU.
- COVID-19 Study Design: The effect of Dietary Glycocalyx Precursor Supplementation on endothelial function, on markers of vascular function and on cardiac performance in patients with COVID-19 infection.
- Aging Study Abstract: Dietary Glycocalyx Precursor Supplementation Restores the Endothelial Glycocalyx and Ameliorates Age-Related Vascular Dysfunction.
- Diabetes Study Abstract: Glycocalyx Restoration Reduces Arterial Stiffness In Diabetic Female Mice.
- Kidney Disease Study Abstract: Endocalyx Pro™ supplementation preserves microvascular health in South Asian type 2 diabetic patients in a randomized controlled trial.
- Psoriasis Study Design: The effect of dietary intervention on endothelial glycocalyx integrity and microvascular perfusion in patients with psoriatic disease.
- Kidney Cell Culture Study Objectives: Protection of the endothelial glycocalyx by Endocalyx Pro™ in murine CKD.
-
Sepsis Study Summary: Endocalyx Pro™ in animal sepsis proposal.
Additional studies are being written and in the approval process will be devoted to these conditions:
- Scleroderma
- Erectile Dysfunction
- Emergency Room Admissions
- Arterial Plaque Development
- Hair Growth
It takes years to complete studies like these, and even after they are completed it can take months before the peer-reviewed research study is released to the public. As soon as results are available, we will share them publicly at Microvascular.com.